Sustained-release amfebutamone [bupropion] is superior to placebo in adults with ADHD

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1278, 2001-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bupropion [amfebutamone] sustained-release (SR) is a potent inhibitor of cytochrome P450 (CYP)2D6

By  

Reactions Weekly, Vol. 1, Iss. 1063, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Agitated delirium associated with therapeutic doses of sustained-release bupropion

By Mack Diana  

International Journal of Clinical Pharmacy, Vol. 34, Iss. 1, 2012-02 ,pp. : 9-12

Springer Publishing Company

Access to resources Recommend Favorite

Sustained-release (SR) bupropion appears to reduce gambling behaviour in pathological gamblers

By  

Inpharma, Vol. 1, Iss. 1514, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Predictors of 12-Month Outcome in Smokers Who Received Bupropion Sustained-Release for Smoking Cessation

By Swan Gary E.  

CNS Drugs, Vol. 22, Iss. 3, 2008-01 ,pp. : 239-256

Adis International

Access to resources Recommend Favorite

Tramadol Sustained-Release Capsules

By Keating Gillian M.  

Drugs, Vol. 66, Iss. 2, 2006-01 ,pp. : 223-230

Adis International

Access to resources Recommend Favorite